StockData

Nutra Pharma Corp (NPHC) stock

NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $806.69KP/E –Yield –

Nutra Pharma operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Nutra Pharma's operating income for the twelve months ending Jun 30, 2026 was -$1.64M. For fiscal 2025 it was -$1.46M. The highest annual figure on record is -$878.42K in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.46M–
FY2024Dec 31, 2024-$878.42K–
FY2023Dec 31, 2023-$886.98K–
FY2022Dec 31, 2022-$1.91M–
FY2021Dec 31, 2021-$1.99M–
FY2020Dec 31, 2020-$924.95K–
FY2019Dec 31, 2019-$1.23M–
FY2018Dec 31, 2018-$1.88M–
FY2017Dec 31, 2017-$1.38M–
FY2016Dec 31, 2016-$2.04M–
FY2015Dec 31, 2015-$5.77M–
FY2014Dec 31, 2014-$2.20M–
FY2013Dec 31, 2013-$2.36M–
FY2012Dec 31, 2012-$2.60M–
FY2011Dec 31, 2011-$3.95M–
FY2010Dec 31, 2010-$3.40M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$435.46K–
Q1 FY2026Mar 31, 2026-$379.25K–
Q4 FY2025Dec 31, 2025-$465.91K–
Q3 FY2025Sep 30, 2025-$356.08K–
Q2 FY2025Jun 30, 2025-$290.53K–
Q1 FY2025Mar 31, 2025-$349.82K–
Q4 FY2024Dec 31, 2024-$178.87K–
Q3 FY2024Sep 30, 2024-$184.75K–
Q2 FY2024Jun 30, 2024-$219.49K–
Q1 FY2024Mar 31, 2024-$295.31K–
Q4 FY2023Dec 31, 2023-$140.22K–
Q3 FY2023Sep 30, 2023-$165.77K–
Q2 FY2023Jun 30, 2023-$182.30K–
Q1 FY2023Mar 31, 2023-$398.69K–
Q4 FY2022Dec 31, 2022-$1.02M–
Q3 FY2022Sep 30, 2022-$236.52K–
Q2 FY2022Jun 30, 2022-$341.09K–
Q1 FY2022Mar 31, 2022-$308.42K–
Q4 FY2021Dec 31, 2021-$496.22K–
Q3 FY2021Sep 30, 2021-$512.31K–
Q2 FY2021Jun 30, 2021-$438.71K–
Q1 FY2021Mar 31, 2021-$541.20K–
Q4 FY2020Dec 31, 2020-$355.22K–
Q3 FY2020Sep 30, 2020-$183.75K–
Q2 FY2020Jun 30, 2020-$198.87K–
Q1 FY2020Mar 31, 2020-$187.10K–
Q4 FY2019Dec 31, 2019-$417.93K–
Q3 FY2019Sep 30, 2019-$235.18K–
Q2 FY2019Jun 30, 2019-$327.85K–
Q1 FY2019Mar 31, 2019-$248.94K–
Q4 FY2018Dec 31, 2018-$351.31K–
Q3 FY2018Sep 30, 2018-$854.25K–
Q2 FY2018Jun 30, 2018-$335.85K–
Q1 FY2018Mar 31, 2018-$337.46K–
Q4 FY2017Dec 31, 2017-$274.94K–
Q1 FY2017Mar 31, 2017-$418.05K–
Q2 FY2016Jun 30, 2016-$608.79K–
Q1 FY2016Mar 31, 2016-$354.61K–

More Nutra Pharma figures

See a number that looks wrong?